Radiotherapy Market to Grow from USD 7.98 Billion in 2026 to USD 10.68 Billion by 2031, at a CAGR of 6.0% – MarketsandMarkets™

Delray Beach, FL, July 22, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global radiotherapy market will grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, at a CAGR of 6.0% during the forecast period. Market growth is driven by the rising global incidence of cancer, increasing healthcare investments, and growing demand for precision oncology treatments. Rapid adoption of advanced technologies such as proton beam therapy, adaptive radiotherapy, stereotactic radiosurgery, MRI-guided radiotherapy, and artificial intelligence-based treatment planning is significantly improving treatment precision while minimizing radiation exposure to surrounding healthy tissues.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567

Key Market Highlights

Market size, 2026: USD 7.98 billion
Market forecast, 2031: USD 10.68 billion
Growth rate: CAGR of 6.0% (2026–2031)
Largest offering segment: Systems
Largest technology segment: External Beam Radiotherapy (EBRT)
Largest application segment: External Beam Radiotherapy (EBRT) Applications
Largest procedure segment: External Beam Radiotherapy Procedures
Largest end-user segment: Hospitals
Fastest-growing regional market: Asia Pacific
Key players: Siemens Healthineers AG (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA Worldwide (Belgium), ViewRay Technologies, Inc. (US), Hitachi Ltd. (Japan), Sumitomo Heavy Industries, Ltd. (Japan), Carl Zeiss Meditec AG (Germany), Koninklijke Philips N.V. (Netherlands), and MIM Software Inc. (US).

Why This Market Matters

Cancer remains one of the leading causes of mortality worldwide, driving increasing demand for highly precise and personalized treatment solutions. Radiotherapy continues to play a central role in modern oncology, with technological advancements enabling more accurate tumor targeting while reducing damage to surrounding healthy tissues. Innovations such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), MRI-guided linear accelerators (MRI-guided LINACs), adaptive radiotherapy, and AI-powered treatment planning are transforming cancer care by improving clinical outcomes, reducing treatment complications, and enhancing workflow efficiency across oncology centers.

Market Overview

The radiotherapy market is witnessing continuous technological evolution, supported by increasing investments in oncology infrastructure and precision medicine. Healthcare providers are adopting advanced radiotherapy platforms, including linear accelerators (LINACs), proton therapy systems, stereotactic radiotherapy systems, MRI-guided radiotherapy, and AI-enabled treatment planning software to improve treatment accuracy and patient outcomes. Emerging innovations such as hypofractionated radiotherapy, image-guided radiation therapy, real-time tumor tracking, and workflow optimization solutions are further expanding the clinical applications of radiotherapy across hospitals and cancer treatment centers.

Analyst Perspective

The radiotherapy industry is transitioning toward intelligent, image-guided, and adaptive treatment ecosystems that combine advanced hardware with AI-driven software and real-time imaging capabilities. Companies integrating artificial intelligence, adaptive planning, motion management, and workflow automation into their radiotherapy portfolios are expected to strengthen their competitive position. Continued investments in precision oncology, coupled with expanding access to advanced cancer care in emerging economies, are expected to create significant long-term opportunities for technology providers.

Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=567

Segment Analysis

By offering, the systems segment is expected to account for the largest share of the radiotherapy market during the forecast period. Growing adoption of technologically advanced radiotherapy equipment, increasing demand for precision oncology, rising cancer incidence, and continuous innovations in external beam radiation therapy and brachytherapy systems are supporting segment growth.

By technology, external beam radiotherapy (EBRT) is expected to dominate the market owing to its ability to deliver highly precise radiation doses while minimizing exposure to surrounding healthy tissues. Increasing adoption of image-guided radiotherapy, intensity-modulated radiotherapy, and advanced linear accelerator technologies continues to drive segment expansion.

By application, external beam radiotherapy (EBRT) applications account for the largest market share due to their widespread use across multiple cancer indications and increasing clinical preference for precision treatment approaches.

By procedure, external beam radiotherapy procedures dominate the market because of their non-invasive nature, high treatment accuracy, lower radiation exposure to adjacent healthy tissues, and increasing integration of advanced treatment technologies.

By end user, hospitals account for the largest share of the radiotherapy market due to high patient volumes, availability of advanced oncology infrastructure, increasing investments in cancer treatment facilities, and the presence of highly trained oncology professionals.

Regional Analysis

Asia Pacific is projected to register the highest CAGR in the radiotherapy market during the forecast period. Market growth is driven by the increasing prevalence of cancer, rapidly aging populations, expanding oncology infrastructure, rising government healthcare spending, growing medical tourism, and increasing adoption of advanced radiotherapy technologies such as linear accelerators, image-guided radiation therapy, and proton therapy across China, India, Japan, South Korea, and Australia.

Key Industry Trends

Growing adoption of proton beam therapy and particle therapy
Increasing implementation of AI-powered treatment planning and automated contouring
Rising use of MRI-guided radiotherapy and adaptive radiotherapy
Expansion of image-guided radiation therapy (IGRT) and stereotactic radiosurgery
Growing demand for hypofractionated radiotherapy protocols
Integration of real-time tumor tracking and workflow optimization technologies
Increasing investments in precision oncology and personalized cancer treatment

Competitive Landscape

The radiotherapy market is characterized by the presence of established global technology leaders and emerging innovators. Siemens Healthineers AG, through its Varian business, continues to strengthen its leadership through advanced radiotherapy systems, proton therapy solutions, and AI-enabled treatment planning technologies. Elekta maintains a strong global presence with comprehensive radiation oncology solutions, including LINACs, MR-LINACs, brachytherapy, and oncology information systems. Accuray continues to expand its market position through innovative CyberKnife, Radixact, and TomoTherapy platforms. Other key participants, including IBA Worldwide, ViewRay Technologies, Hitachi, Sumitomo Heavy Industries, Carl Zeiss Meditec, Philips, Mevion Medical Systems, and Panacea Medical Technologies, continue investing in technological innovation, strategic collaborations, and global expansion to strengthen their competitive positions.

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Report Code: MD 1773 | Published: 3 June 2026 | Report Pages: 350 | Market Data Tables: 304 | Figures: 53

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.